India restricts sale of off-patent TB medicines to government channels to combat drug resistance
'The drug should be used as per Standards of TB Care in India (STCI) guidelines with the conditional access through the National TB Elimination Programme only," the apex drug regulator said in a letter to all states and Union Territories.
The Drugs Controller General of India (DCGI) emphasised that the labels of all such TB drugs and their packaging should carry a warning in a box with a red background, stating: "For the use in National TB Elimination Programme only."
It said these medicines are critical drugs that are reserved for the treatment of Multi-Drug-Resistant TB infection. Availability of such drugs in the open market through retail outlets may lead to indiscriminate use and development of resistance, causing treatment failure.
Also Read | Govt disburses ₹3,649 crore to 12 million tuberculosis patients for nutrition
The regulator asked the states and UTs to amend the conditions of all licences already granted to manufacture such drugs and incorporate the clause on their restricted usage. It also sought action-taken reports from them.
The DGCI directive pertains to drugs such as Bedaquiline (100 mg and 20 mg), Delamanid (50 mg and 25 mg), Pretomanid (100 mg), and Rifapentine (150 mg and 300 mg), said an official with knowledge of the matter.
Patents for Bedaquiline and Delamanid expired last year, leading to their widespread manufacture by several pharmaceutical companies and their subsequent open availability in private drug stores.
The Central TB Division had raised concerns about the easy availability of these TB drugs in October last year and sought the DCGI's intervention to regulate their sale.
Latent TB infection
The drugs are vital components of the combination therapy for latent TB infection, when an infected person has no symptoms and cannot spread the disease to others, and Multi-Drug-Resistant Tuberculosis (MDR-TB). Rifapentine and a fixed dose combination of Rifapentine and Isoniazid have been approved for the treatment of latent TB infection.
Last year, India rolled out a six-month MDR-TB regimen called BPaL (Bedaquiline, Pretomanid and Linezolid), which has a very high success rate and treatment outcome. These medicines are provided free to patients in both government and private healthcare set-ups.
TB medicines are approved for import/manufacturing by the Central Drugs Standard Control Organisation in consultation with the Subject Expert Committee and experts from the Central TB Division at the ministry of health and family welfare.
Also Read | New AI model could guide personalised treatments for tuberculosis: Study
'The matter was discussed last week during the Drugs Consultative Committee meeting chaired by the DCGI," the person said. 'These drugs will primarily be distributed through government channels under the National TB Elimination Programme to hospitals and TB treatment centres, allowing for detailed tracking of manufacturers and patients."
Elimination campaign
Last month, Prime Minister Narendra Modi chaired a high-level meeting on the National TB Elimination Programme and called for strategies to be scaled up to meet India's commitment to eliminate TB.
At a recent 100-Day TB elimination campaign, over almost 720,000 TB cases were detected across the country, including 285,000 asymptomatic cases, highlighting the challenge and the importance of controlled drug access.
Also Read | Lupin recalls over 16,000 bottles of generic tuberculosis drug in the US citing manufacturing issue
TB is a contagious disease caused by a bacterium called Mycobacterium tuberculosis. It mainly affects the lungs. It can also affect other parts of the body such as the brain, the kidneys, or the spine.
India reported 2.6 million TB cases last year. Despite the challenges, India has made significant strides in its fight against TB.
The WHO Global TB Report 2024 indicates an 18% reduction in TB incidence and a 21% decline in TB mortality from 2015 to 2023, double the global pace. With an 85% treatment coverage, India is steadily nearing its TB elimination target.
Queries sent to the health ministry spokesperson and the DCGI's office were unanswered.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
Business Standard
a day ago
- Business Standard
Work on HC-ordered CDSCO panel on weight loss drug may begin mid-July
A Delhi HC directive to examine unregulated use of weight loss drugs may lead to a CDSCO expert panel by mid-July, possibly led by DCGI with pharma and govt representation New Delhi The Central Drugs Standard Control Organisation (CDSCO) may begin work on forming a court-ordered expert panel to examine the unregulated use of weight loss drugs by mid-July, according to sources. Officials in the know told Business Standard that the panel could be led by the Drug Controller General of India (DCGI) and may include the Director General of Health Services (DGHS) and officials from the Department of Pharmaceuticals as members. 'There are discussions that pharmaceutical associations would be asked to join as well to give an industry viewpoint,' an official aware of the matter said. The CDSCO did not respond to queries emailed by Business Standard till the time of going to print. The panel is also expected to review the possible unregulated use of anti-diabetic drugs for weight loss within the court's three-month deadline to respond to the petitioner. The directive followed a Public Interest Litigation (PIL) filed by fitness entrepreneur Jitendra Chouksey, raising concerns over the marketing approval granted for drugs such as semaglutide, tirzepatide and liraglutide for weight management despite limited safety data and a lack of India-specific clinical trials. The direction comes amid a wave of weight loss drug launches by multinational pharmaceutical companies in India. US-based Eli Lilly launched Mounjaro (tirzepatide) in March, while Danish drugmaker Novo Nordisk launched Wegovy (semaglutide) last month. These drugs, administered as once-a-week injections, belong to a class of therapies known as glucagon-like peptide-1 (GLP-1) receptor agonists, which help regulate blood sugar and slow digestion, making users feel full for longer. According to standard guidelines for obesity management medications (OMMs), weight loss drugs are approved for patients with a Body Mass Index (BMI) over 27 and at least one obesity-related comorbidity, such as Type-2 diabetes, hypertension or high cholesterol. However, doctors report growing interest from individuals who do not meet the medical criteria. 'We are strictly discouraging its use for cosmetic purposes or in patients who do not meet the clinical threshold,' a Delhi-based endocrinologist said.
&w=3840&q=100)
First Post
a day ago
- First Post
Is your makeup safe? Why is India looking to ban mercury-based cosmetics?
The next time you apply that skin-lightening cream or your eye makeup, think again. It might contain the harmful chemical element mercury. The Government of India is now even mulling a ban on mercury-based cosmetics owing to the dangers they pose to the human body read more The Indian government is now considering a ban on mercury-based cosmetics, Most often mercury is used in eye makeup and in skin-lightening creams. Representational image/Pixabay The death of actor-model Shefali Jariwala has sparked a national debate on the safety of anti-ageing and skin-whitening products. As the discussion rages on, have you ever wondered what's in your makeup and if it could cause more harm than good? It seems the government of India has asked this question and is now considering a ban on mercury-based cosmetics, citing the dangers it poses to the human body. News reports state that the Centre is mulling a ban on mercury-based cosmetics after receiving a recommendation from a Drugs Controller General of India (DCGI) to ban such formulations — in accordance to the global Minamata Convention, which is designed to protect human health and the environment from the harmful effects of mercury and its compounds. STORY CONTINUES BELOW THIS AD What is the government's new move against makeup? The Centre is considering a ban on all mercury-based cosmetics containing more than one ppm (parts per million of mercury) based on the recommendations passed by the DCGI. 'Mercury use in the formulation of cosmetics has to be stringently discouraged/stopped,' the sub-committee recommended, according to minutes of a meeting reviewed by Mint. In India, mercury content is already limited under Rule 39 (5) of Cosmetics Rules, 2020. In eye make-up, the level of mercury should not exceed 70 parts per million (0.007 per cent), calculated as the metal, as a preservative. In other finished cosmetic products, 'unintentional mercury shall not exceed 1 ppm'. However, the DCGI wants stricter standards, which align with the Minamata Convention that calls for a complete ban on the use of mercury. Now, if the government does adhere to the DCGI's recommendations, it would be looking to identify cosmetics containing mercury and phase out their sale from the $20-billion Indian cosmetics market and from online platforms this year. For this purpose, the government may ask cosmetic companies to self-declare whether they use mercury. This will be followed by surprise lab tests and random sampling by regulators such as the Central Drugs Standard Control Organisation (CDSCO). As an official told the Mint, 'Keeping mercury stocks alive for even 'safe' proportions maintains its trade, creating multiple points for potential environmental contamination during stocking, manufacturing, procuring, and transportation. 'So, the logical step is to require manufacturers to self-declare their use of mercury, propose alternative formulations, and give them a strict deadline for phasing out mercury. These companies will also be required to give mandatory certification and random testing by the CDSCO by picking samples from the market.' STORY CONTINUES BELOW THIS AD The WHO has warned that from anti-ageing creams and eye makeup to skin-whitening lotions and nail polishes, mercury has found its way into a wide range of beauty products. Representational image/Pixabay How dangerous is mercury in cosmetics? Mercury has often been used in makeup products such as anti-ageing creams and eye makeup to skin-whitening lotions and nail polishes. Experts note that mercury has been added to cosmetics as it is has the ability to whiten skin. The World Health Organisation (Who) has earlier issued a warning against the use of mercury noting that the toxic chemical is used in skin lightening soaps, creams and cosmetics like eye makeup, cleansing products and mascara. However, makeup formulations containing mercury pose dangers to the human body. Exposure to mercury can cause irritation. According to the US' Food and Drug Administration (FDA), users could develop redness, itching and rashes. It could also lead to hives. Experts also note that prolonged use of mercury-based cosmetics could results in dermatitis, which is inflammation or the skin, or in extreme cases even cause permanent skin discolouration. Mercury-based cosmetics could also penetrate the skin barrier and enter the bloodstream, leading to systemic toxicity; it could cause damage to the central nervous system, which could be seen in symptoms such as tremors, memory problems, mood swings, and cognitive dysfunction. The use of mercury-based makeup could also lead to kidney damage and can weaken the immune system, making the body more vulnerable to infections and diseases. In fact, in 2022, there was a case of a woman in Minnesota in the United States, who lost part of her vision, as a result of mercury poisoning, most likely from using beauty creams containing high levels of the toxic chemical. STORY CONTINUES BELOW THIS AD Experts also note that mercury in cosmetics is eventually discharged into wastewater. It enters the environment, where it becomes methylated, and enters the food chain as highly toxic methylmercury in fish. Pregnant women who consume fish containing methylmercury can transfer it to their offspring, resulting in neurological conditions. 'Mercury poisoning from skin-whitening creams can be very serious, as it causes nervous system damage that can be permanent,' said Dr Eric Lavonas, a toxicologist with Rocky Mountain Poison and Drug Safety in Denver, Colorado, and a spokesperson for the American College of Emergency Physicians, to F_ox News._ The one way to protect yourself from mercury poisoning is read the labels of the cosmetics you buy. If it contains mercury, refrain from buying it. Representational image/AFP How prevalent is the use of mercury in makeup? But despite the dangers of mercury, it is still used in cosmetics. In 2022, the Zero Mercury Working Group tested 271 products bought in 15 countries over a 13-month period and found nearly half to be contaminated with the dangerous heavy metal at levels above 1 part per million (ppm). Michael Bender, international coordinator with the Mercury Policy Project, told The Guardian, 'We're not finding 1 ppm – we're finding products that are hundreds or thousands or tens of thousands of times above [1ppm. These levels are astronomical.' And this January, cosmetics worth over Rs 7 lakh were seized for failing to adhere norms in Kerala. Tests conducted on lipstick and face cream samples revealed mercury levels exceeding permissible limits, with some samples showing mercury levels 12,000 times higher than allowed. STORY CONTINUES BELOW THIS AD How can customers protect themselves? If you want to steer clear of mercury-based products, the first thing to do is read — read the product labels carefully. Also, steer clear of skin-lightening creams as they tend to contain mercury. Experts also note that customers should avoid buying 'suspiciously' cheap products and shop from reputable stores. As Michelle Wong, a Sydney-based science educator and beauty influencer, told ABC News, 'If there's things that don't seem right, things like misspelt words on the product, then it probably isn't very legitimate.' With inputs from agencies
Mint
2 days ago
- Mint
Mercury ban in cosmetics: Why it's harmful to your health and where it might be hiding
That skin-lightening cream or anti-ageing serum promising a glow overnight? It might be hiding something dangerous. The Indian government is now considering a ban on mercury-based cosmetics, following a recommendation by a central drug regulation panel. If implemented, this move would phase out mercury-containing products from the Indian market, including popular makeup, creams and skincare sold online. Mercury isn't just bad for your skin, it can harm your brain, nerves, and even your family's health. Mercury is sometimes used in skin-lightening creams, anti-wrinkle products, and eye makeup to deliver quick results, according to the FDA. But over time, it can do serious damage. Skin rashes Discolouration Thinning skin Permanent scarring Mood changes, memory issues, and numbness Long-term neurological harm Worse still? When you use mercury-laced products, your family can be exposed too, through shared towels, bedding, or even just the air. Up to 70 parts per million (ppm) of mercury in eye makeup Just 1 ppm in other cosmetics But that might soon change. The government is looking to ban anything with more than 1 ppm, bringing India in line with global safety standards under the Minamata Convention, a UN-backed treaty. Cosmetic brands may soon need to self-declare if they use mercury. Surprise lab tests and random product checks are also on the cards. An official told Mint: 'We're asking companies to share alternatives and will set a hard deadline to phase mercury out.' Here's what beauty-conscious shoppers should do: Read the label. If a product doesn't list ingredients, skip it. Look out for terms like 'mercurous chloride,' 'calomel,' or 'mercuric iodide', these are mercury. Wash your hands thoroughly if you've used anything questionable. Dispose of products safely, not in the regular bin. • Pregnant women • Young children and babies Mercury can pass through breast milk or affect brain development in kids.
